Town Square

Stanford begins clinical trials to expand Pfizer vaccine access to young children

Original post made on Apr 16, 2021

Stanford Health Care has begun laying the clinical groundwork to expand COVID-19 vaccine eligibility to the country's youngest children, joining in a nationwide trial to see how safe the Pfizer vaccine is for people ages 2 to 5.

Read the full story here Web Link posted Friday, April 16, 2021, 10:51 AM

Comments

Don't miss out on the discussion!
Sign up to be notified of new comments on this topic.

Town Square

Stanford begins clinical trials to expand Pfizer vaccine access to young children

Stay informed.

Index